Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioXcel Therapeutics, Inc. - Common Stock (NQ:BTAI)

2.035 +0.015 (+0.74%)
Streaming Delayed Price Updated: 2:48 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 475,324
Open 2.040
Bid (Size) 2.020 (3)
Ask (Size) 2.030 (7)
Prev. Close 2.020
Today's Range 1.976 - 2.060
52wk Range 1.170 - 13.28
Shares Outstanding 6,620,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
BioXcel Drug Calms Agitation At Home For Schizophrenia, Bipolar Patients
BioXcel's Phase 3 trial shows BXCL501 effectively reduces agitation in bipolar and schizophrenia patients, supporting its at-home treatment use. 
Via Benzinga

Performance

YTD
-67.6%
-67.6%
1 Month
-20.5%
-20.5%
3 Month
+55.3%
+55.3%
6 Month
+14.6%
+14.6%
1 Year
-82.2%
-82.2%

More News

Read More
BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study
Via Stocktwits
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
EXCLUSIVE: August's 20 Most-Searched Tickers On Benzinga Pro – Where Do Opendoor, Palantir, BitMine Immersion, Apple Stock Rank?
Via Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Which stocks are experiencing notable movement on Wednesday?
Via Chartmill
BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later
Via Stocktwits
BioXcel Sparks Retail Frenzy As Stock Soars Ahead Of Phase 3 Results For Bipolar, Schizophrenia Drug
Via Stocktwits
BioXcel Stock In Focus: FDA Issues Positive Early Feedback Ahead Of Key Meeting On Expanded Psychiatric Label
Via Stocktwits
BioXcel Seeks FDA Label Expansion For Schizophrenia Treatment
Via Benzinga
The market is filled with gapping stocks in Wednesday's session.
Via Chartmill
Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BioXcel Stock Surges 19% In After-Hours Trading: What You Need To Know
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Get insights into the top gainers and losers of Tuesday's after-hours session.
Via Chartmill
Tuesday's pre-market session: top gainers and losers
Via Chartmill
Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!
Via AB Newswire
Topics Artificial Intelligence
BioXcel Therapeutics (BTAI) Stock Is Surging Monday: What's Going On?
Via Benzinga
Topics Artificial Intelligence
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Dayforce Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BioXcel Stock In Focus: FDA Issues Positive Early Feedback Ahead Of Key Meeting On Expanded Psychiatric Label (This works)
Via Stocktwits
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga

Frequently Asked Questions

Is BioXcel Therapeutics, Inc. - Common Stock publicly traded?
Yes, BioXcel Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does BioXcel Therapeutics, Inc. - Common Stock trade on?
BioXcel Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioXcel Therapeutics, Inc. - Common Stock?
The ticker symbol for BioXcel Therapeutics, Inc. - Common Stock is BTAI on the Nasdaq Stock Market
What is the current price of BioXcel Therapeutics, Inc. - Common Stock?
The current price of BioXcel Therapeutics, Inc. - Common Stock is 2.035
When was BioXcel Therapeutics, Inc. - Common Stock last traded?
The last trade of BioXcel Therapeutics, Inc. - Common Stock was at 10/31/25 02:48 PM ET
What is the market capitalization of BioXcel Therapeutics, Inc. - Common Stock?
The market capitalization of BioXcel Therapeutics, Inc. - Common Stock is 13.47M
How many shares of BioXcel Therapeutics, Inc. - Common Stock are outstanding?
BioXcel Therapeutics, Inc. - Common Stock has 13M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.